FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

22350911000001109: Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 29-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1613201000001112 Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1613221000001117 Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73697001000001113 Risedronate sodium 35mg tablets (Aurobindo Pharma Ltd) 4 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
73697101000001114 Risedronate sodium 35mg tablets (Aurobindo Pharma Ltd) 4 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Is a Risedronate sodium 35mg tablets 4 tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Has AMP Risedronate sodium 35mg tablets (Milpharm Ltd) true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Has specific active ingredient Risedronate sodium true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Risedronate sodium 35mg tablets (Milpharm Ltd) 4 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start